DeRetta C. Rhodes - 11 Dec 2025 Form 4 Insider Report for Atlanta Braves Holdings, Inc. (BATRK)

Role
EVP, Chief People & Culture Officer
Signature
/s/ Kerry T. Wenzel, Attorney-in-Fact
Issuer symbol
BATRK
Transactions as of
11 Dec 2025
Transactions value $
-$32,800
Form type
4
Filing time
15 Dec 2025, 16:01:07 UTC
Previous filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rhodes DeRetta C. EVP, Chief People & Culture Officer C/O ATLANTA BRAVES HOLDINGS, INC., 755 BATTERY AVENUE SE, ATLANTA /s/ Kerry T. Wenzel, Attorney-in-Fact 15 Dec 2025 0002035944

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BATRK Series C Common Stock Options Exercise $0 +1.88K +37.71% $0.00 6.87K 11 Dec 2025 Direct F1
transaction BATRK Series C Common Stock Sale -$32.8K -826 -12.03% $39.71 6.04K 12 Dec 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BATRK Restricted Stock Units - BATRK Options Exercise $0 -1.88K -49.99% $0.00 1.88K 11 Dec 2025 Series C Common Stock 1.88K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit converted into one share of Series C Common Stock.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
F3 Reflects the weighted average sale price. The range of prices for such transaction is $39.41 to $40.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4 Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
F5 One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Remarks:

EVP, Chief People & Culture Officer